ATE37984T1 - Pharmazeutische zusammensetzung welche 5acetamido-3,5-dideoxy-d-glycero-dgalactononulosamins|ure cytidin monophosphat enthaelt. - Google Patents

Pharmazeutische zusammensetzung welche 5acetamido-3,5-dideoxy-d-glycero-dgalactononulosamins|ure cytidin monophosphat enthaelt.

Info

Publication number
ATE37984T1
ATE37984T1 AT84102059T AT84102059T ATE37984T1 AT E37984 T1 ATE37984 T1 AT E37984T1 AT 84102059 T AT84102059 T AT 84102059T AT 84102059 T AT84102059 T AT 84102059T AT E37984 T1 ATE37984 T1 AT E37984T1
Authority
AT
Austria
Prior art keywords
glycero
dideoxy
dgalactononulosamine
5acetamido
ure
Prior art date
Application number
AT84102059T
Other languages
English (en)
Inventor
Pietro Miccoli
Enio Decorte
Original Assignee
Crc Ricerca Chim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT83341/83A external-priority patent/IT1175061B/it
Priority claimed from IT83371/83A external-priority patent/IT1175084B/it
Application filed by Crc Ricerca Chim filed Critical Crc Ricerca Chim
Application granted granted Critical
Publication of ATE37984T1 publication Critical patent/ATE37984T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/305—Pyrimidine nucleotides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT84102059T 1983-03-01 1984-02-28 Pharmazeutische zusammensetzung welche 5acetamido-3,5-dideoxy-d-glycero-dgalactononulosamins|ure cytidin monophosphat enthaelt. ATE37984T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT83341/83A IT1175061B (it) 1983-03-01 1983-03-01 Applicazione terapeutica del citidin monofosfato dell'acido 5-acetamido-3,5-dideossi-d-glicero-d-galattononulo saminico
IT83371/83A IT1175084B (it) 1983-04-20 1983-04-20 Metodo per la preparazione del citidin monofosfato dell'acido 5-acetamido-3,5-dideossi-d-glicero-d-galattononulo-saminico
EP84102059A EP0120328B1 (de) 1983-03-01 1984-02-28 Pharmazeutische Zusammensetzung welche 5-Acetamido-3,5-Dideoxy-D-Glycero-D-Galactononulosaminsäure Cytidin Monophosphat enthält

Publications (1)

Publication Number Publication Date
ATE37984T1 true ATE37984T1 (de) 1988-11-15

Family

ID=26330056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84102059T ATE37984T1 (de) 1983-03-01 1984-02-28 Pharmazeutische zusammensetzung welche 5acetamido-3,5-dideoxy-d-glycero-dgalactononulosamins|ure cytidin monophosphat enthaelt.

Country Status (6)

Country Link
US (2) US4704361A (de)
EP (2) EP0263533A3 (de)
JP (1) JPH0276894A (de)
AT (1) ATE37984T1 (de)
CA (1) CA1219539A (de)
DE (1) DE3474632D1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61204190A (ja) * 1985-03-06 1986-09-10 Kanto Ishi Pharma Co Ltd グリコシド及びその製造方法
WO1990004400A1 (en) * 1988-10-27 1990-05-03 Massachusetts Institute Of Technology PROCESS FOR INCREASING PHOSPHATIDYLCHOLINE $i(IN VIVO)
US5109126A (en) * 1988-12-06 1992-04-28 Worcester Foundation For Experimental Biology 5'[2'(3')-O-(2,4,6-trinitrophenyl) pyprimidine nucleoside]diphosphate 1-glycosides
US5059535A (en) * 1989-04-12 1991-10-22 Chembiomed, Ltd. Process for the separation and purification of sialyl transferases
SG49879A1 (en) * 1991-07-17 2001-03-20 Forschungszentrum Juelich Gmbh A process for the preparation of activated sialic acids
ATE174925T1 (de) * 1991-10-15 1999-01-15 Scripps Research Inst Herstellung von fucosylierten kohlenhydraten durch enzymatische fucosylierungs-synthese der zuckernukleotide; und in situ regeneration von gdp-fucose
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5958896A (en) * 1997-08-08 1999-09-28 The Mclean Hospital Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
ES2425114T3 (es) 2000-03-16 2013-10-11 The Mclean Hospital Corporation CDP-colina y uridina para el tratamiento del abuso del acohol
AU2003291368A1 (en) * 2002-11-08 2004-06-03 The Mclean Hospital Corporation Compounds for the treatment of tobacco dependence and withdrawal
US20050038343A1 (en) * 2003-07-10 2005-02-17 Alfred E. Mann Institute For Biomedical Research At The University Of Southern California Apparatus and method for locating a bifurcation in an artery
WO2005034874A2 (en) * 2003-10-08 2005-04-21 The Mclean Hospital Corporation Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
JP2007508315A (ja) * 2003-10-08 2007-04-05 ザ マクレーン ホスピタル コーポレーション ω−３脂肪酸を含む組み合わせを用いて、精神障害、物質乱用障害、および他の障害を治療する方法
EP1765364A4 (de) * 2004-06-10 2010-09-22 Mclean Hospital Corp Pyrimidine, wie z:b: cytidin, bei der behandlung von patienten mit bipolaren störungen
EP1765075A4 (de) * 2004-06-10 2010-11-10 Mclean Hospital Corp Pyrimidine, wie z.b. uridin; bei der behandlung von patienten mit manisch-depressiver psychose
EP1784199A4 (de) * 2004-08-11 2010-06-23 Mclean Hospital Corp Verbindungen zur behandlung von marihuana-abhängigkeit, entzug und konsum
US20080176790A1 (en) 2004-10-29 2008-07-24 Defrees Shawn Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20080248959A1 (en) 2006-07-21 2008-10-09 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
AU2008237411B2 (en) 2007-04-03 2013-10-03 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
EP2626079A3 (de) 2008-02-27 2014-03-05 Novo Nordisk A/S Konjugierte Faktor-VIII-Moleküle
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2648759C3 (de) * 1976-10-27 1979-05-31 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisierungsmittel für Enzyme
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
US4704361A (en) 1987-11-03
EP0120328A3 (en) 1985-01-23
EP0120328A2 (de) 1984-10-03
CA1219539A (en) 1987-03-24
EP0120328B1 (de) 1988-10-19
DE3474632D1 (en) 1988-11-24
EP0263533A2 (de) 1988-04-13
JPH0276894A (ja) 1990-03-16
EP0263533A3 (de) 1990-05-30
US5070079A (en) 1991-12-03

Similar Documents

Publication Publication Date Title
ATE37984T1 (de) Pharmazeutische zusammensetzung welche 5acetamido-3,5-dideoxy-d-glycero-dgalactononulosamins|ure cytidin monophosphat enthaelt.
MacNutt The enzymically catalysed transfer of the deoxyribosyl group from one purine or pyrimidine to another
Appel Purification and kinetic properties of brain orotidine 5′-phosphate decarboxylase
ES2061416T1 (es) Ribocimas modificadas.
Rahman et al. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats
Narumi et al. Activation and phosphorylation of carbonic anhydrase by adenosine 3′, 5′-monophosphate-dependent protein kinases
FI886050A7 (fi) Amperometrinen menetelmä 1,4-dihydronikotiiniamidiadeniinidinukleotidin (NADH) kvantitatiiviseksi määrittämiseksi liuoksessa
RO92477A (ro) Procedeu de preparare pe cale microbiologica a l-carnitinei
Cutler Comments on the validity of the use of lead nitrate for the cytochemical study of adenylate cyclase.
EP0096547B1 (de) Verfahren zur Herstellung von Uridin-diphosphat-N-acetylgalactosamin
EP0304215A3 (de) Phosphorylierungsreagenz und Verfahren zu seiner Verwendung
ES2113845T3 (es) Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.
HU896337D0 (en) Process for the preparation of novel lisoganglyoside derivatives
TNSN88118A1 (fr) Procede de preparation de derives des ginkgolides
SE8401797D0 (sv) Enzympapper och forfarande for framstellning derav
DE3665320D1 (en) Stabilization of peroxidase activity in solution
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
EP0189322A3 (de) Enzymatische Synthese von S-Adenosylmethionin
SE8504657L (sv) Nya 5-fluor-2'-deoxiuridinderivat och salter derav, forfarande for deras framstellning och antitumormedel innehallande dessa
PL286248A1 (en) Method of obtaining novel derivatives of gangliosides
ATE89604T1 (de) Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
Lowy et al. A role of liver adenosine in the renewal of the adenine nucleotides of human and rabbit erythrocytes
JPS6485202A (en) Palatinose condensate, its preparation and its utilization
Salaun et al. Influence of phosphate concentrations on intra and extracellular adenylic compounds.
FR2588568B1 (fr) Procede de preparation de fructose pauvre en glucose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties